Pharmaceutical researchers in the United Kingdom are using the artificial intelligence tool AlphaFold to develop new psychedelic drugs, according to research released last month. The research, which ...

Google DeepMind cofounder and CEO Demis Hassabis and John Jumper, a senior researcher at the company, shared the 2024 Nobel Prize for Chemistry for their work on AlphaFold, an AI model that predicts ...

They build our bodies and orchestrate the molecular processes in cells that keep them healthy. They also present a wealth of targets for new medications. From everyday pain relievers to sophisticated ...

When John Jumper got the call earlier this month from the Royal Swedish Academy of Sciences that he was winning the Nobel Prize, he almost didn’t answer. The director of Google DeepMind, the tech ...

Posts from this topic will be added to your daily email digest and your homepage feed. AlphaFold 3 uses the same method as AI image generators to predict how different molecules fit together.

Over the past six years, artificial intelligence has been significantly influenced by 12 foundational research papers. One pivotal moment was the ...

Read Jennifer Doudna’s tribute to Demis Hassabis here. Demis Hassabis learned he had won the 2024 Nobel Prize in Chemistry ...

An AI breakthrough from an Alphabet-owned startup is speeding up the hunt for new drugs. The technology, called AlphaFold2, has been used by over 1 million researchers to study proteins. Several ...

Insilico Medicine (“Insilico”), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has achieved a significant breakthrough in the application of multiple ...

While many businesses continue to seek AI’s killer app, biochemists have already found it. That application is protein folding. This week marks the five-year anniversary of the debut of Alpha Fold 2, ...